These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3158422)

  • 21. Guanadrel. A new antihypertensive drug.
    Dunn MI; Dunlap JL
    JAMA; 1981 Apr; 245(16):1639-42. PubMed ID: 7206175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanadrel sulfate: a postganglionic sympathetic inhibitor for the treatment of mild to moderate hypertension.
    Palmer JD; Nugent CA
    Pharmacotherapy; 1983; 3(4):220-9. PubMed ID: 6351026
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic and renal haemodynamics during antihypertensive treatment with propranolol.
    Birkenhäger WH; Krauss XH; Kolsters G; Zaal GA; Schalekamp MA
    Brux Med; 1973 Nov; Spec No(0):183-93. PubMed ID: 4803445
    [No Abstract]   [Full Text] [Related]  

  • 26. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Bazika V; Neuzil P; Tiserová J; Hrabovský F
    Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of guanadrel in elderly hypertensive patients.
    Owens SD; Dunn MI
    Arch Intern Med; 1988 Jul; 148(7):1515-8. PubMed ID: 3382297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 39. Guanadrel (Hylorel)--a new antihypertensive drug.
    Med Lett Drugs Ther; 1983 Oct; 25(646):95-6. PubMed ID: 6621504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Oct; 2(38):2539-46. PubMed ID: 4148700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.